Your browser doesn't support javascript.
loading
Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients.
Solca, Federica; Aiello, Edoardo Nicolò; Torre, Silvia; Carelli, Laura; Ferrucci, Roberta; Verde, Federico; Ticozzi, Nicola; Silani, Vincenzo; Monti, Alessia; Poletti, Barbara.
Afiliação
  • Solca F; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Aiello EN; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Torre S; PhD Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • Carelli L; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Ferrucci R; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Verde F; Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milano, Italy.
  • Ticozzi N; ASST Santi Paolo e Carlo, San Paolo University Hospital, Milan, Italy.
  • Silani V; IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
  • Monti A; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Poletti B; Department of Pathophysiology and Transplantation, 'Dino Ferrari Center', Università degli Studi di Milano, Milan, Italy.
Eur J Neurol ; 30(3): 606-611, 2023 03.
Article em En | MEDLINE | ID: mdl-36445001
ABSTRACT
BACKGROUND AND

PURPOSE:

This study aimed at estimating the prevalence of language impairment (LI) in a large, clinic-based cohort of non-demented amyotrophic lateral sclerosis (ALS) patients and assessing its underpinnings at motor and non-motor levels.

METHODS:

Non-demented ALS patients (N = 348) underwent the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), as well as an assessment of behavioural/psychiatric and motor-functional features. The prevalence of LI was estimated based on the proportion of patients showing a performance below the age- and education-adjusted cut-off on the ECAS-Language. Multiple regression models were run to assess the determinants of language functioning and impairment.

RESULTS:

The prevalence of LI was 22.7%. 46.6% of the variance of ECAS-Language scores remained unexplained, with only the ECAS-Executive positively predicting them (p < 0.001; η2  = 0.07). Similarly, only a lower score on the ECAS-Executive predicted a higher probability of a below cut-off ECAS-Language performance (p < 0.001). Spelling and Naming tasks were the major drivers of ECAS-Language performance.

CONCLUSIONS:

This study suggests that, in non-demented ALS patients, LI occurs in ≈23% of cases, is significantly driven by executive dysfunction but, at the same time, partially independent of it and is not associated with other motor or non-motor features.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Esclerose Lateral Amiotrófica / Transtornos do Desenvolvimento da Linguagem Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva / Esclerose Lateral Amiotrófica / Transtornos do Desenvolvimento da Linguagem Idioma: En Ano de publicação: 2023 Tipo de documento: Article